Cilostazol for Secondary Prevention of Stroke: Should the Guidelines Perhaps Be Extended?
Cilostazol belongs to the new generation antiplatelet agents that have been introduced and studied regarding a potential role in cardiovascular disease prevention or treatment. Although data on peripheral artery disease are sufficient, and the drug has been recommended as first line treatment for in...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Medrang
2017-09-01
|
| Series: | Vascular Specialist International |
| Subjects: | |
| Online Access: | http://www.vsijournal.org/journal/view.html?doi=10.5758/vsi.2017.33.3.89 |